Rocket Pharmaceuticals Inc RCKT
News
Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference
Rocket Pharmaceuticals Highlights FDA-Aligned Pivotal Phase 2 Trial and Updated Clinical Findings for RP-A501 Following Danon Disease Investor Webinar
Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital
Rocket Pharma Shares Climb Premarket After FDA Supports Continuation of Trial
Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Rocket Receives FDA Approval for Genetic Immunodeficiency Treatment
Rocket Pharmaceuticals Shares Surge after FDA Accepts Drug Application Resubmission
FDA Accepts Rocket Pharmaceuticals' BLA Resubmission for Rare Genetic Disorder Treatment
